Delivery Order SPE2DB22D2206-SPE2DB23FJP68
- Not listed
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for the purchase of methotrexate injection vials. The firm fixed price order is being fulfilled under the Prime Vendor Pharmaceutical program and calls for the delivery of 4561400454 units of methotrexate 50 mg/2 ml vials to a facility in Conshohocken, Pennsylvania. Performance will take place between July 3 and July 5, 2023. No subcontractors or set aside designations were identified. The Defense...
- The Defense Logistics Agency awarded a $37,760 delivery order to Amerisourcebergen Drug Corporation for methotrexate injection vials. The firm fixed price order is for 4562180881 units of methotrexate at 50 mg/2 ml per vial, with a place of performance in Conshohocken, Pennsylvania. The period of performance is September 14-15, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services and combatant...
- The Defense Logistics Agency awarded a $37,760 delivery order to Amerisourcebergen Drug Corporation for methotrexate injection vials. The firm fixed price order is for delivery of 4561327540 units of methotrexate, a chemotherapy drug, in 2mL vials. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period concluding on June 26, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain...
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for methotrexate 50 mg/2 ml vials. The firm fixed price order is for a one day period of performance from September 18-19, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global supply chain and is likely procuring the methotrexate to support treatment of certain cancers or...
- The Defense Logistics Agency awarded a $37,760 delivery order to Amerisourcebergen Drug Corporation for methotrexate injections. The firm fixed price order is for the delivery of 4562252108 units of methotrexate at 50 mg/2 ml per vial with a total of 2 ml per vial. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania between September 20-21, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. military and other government...
- The Defense Logistics Agency awarded a $9,910 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by June 23, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for methotrexate is consistent with the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for the provision of 4561500678, methotrexate 50 mg/2 ml vials. The firm fixed price order is to supply 2 ml vials of the drug from Amerisourcebergen's Conshohocken, Pennsylvania location. Performance will take place between July 14-17, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this order supports DOD medical readiness and...
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for 4561422305, methotrexate 50 mg/2 ml vials. The firm fixed price order is for delivery of the pharmaceutical product to a location in Conshohocken, Pennsylvania, with performance required from July 6-7, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order for methotrexate, a chemotherapy and anti-inflammatory drug, is consistent with the...
- The Defense Logistics Agency awarded a $37,760 delivery order to Amerisourcebergen Drug Corporation for methotrexate injection vials. The firm fixed price order is being fulfilled under the Prime Vendor Program prime vendor contract vehicle. Amerisourcebergen will deliver 4562180623 units of methotrexate, a chemotherapy drug, in 2mL vials from its facility in Conshohocken, Pennsylvania to an unknown customer or customers of the Defense Logistics Agency. Performance is required between...
- The Defense Logistics Agency awarded a $97,070 delivery order to Amerisourcebergen Drug Corporation for the supply of 250 mg/10 ml vials of methotrexate. The firm fixed price order calls for the delivery of 10 ml vials of the chemotherapy drug to a facility in Conshohocken, Pennsylvania by July 17, 2023. Amerisourcebergen will perform as the prime contractor, supplying the Defense Logistics Agency with the requested pharmaceutical to support Department of Defense health programs. The order was...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FJP68Delivery Order
The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for methotrexate injection vials. The firm fixed price order is being fulfilled under the Prime Vendor Pharmaceutical program and will provide 4561707418 units of methotrexate 50 mg/2 ml vials from Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support military readiness. This order for methotrexate, a chemotherapy and anti-inflammatory drug, is consistent with the agency's mission to procure pharmaceuticals and medical supplies for military treatment facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19 | 8/4/23 |